CAMK2G and atrial fibrillation: CaMKII is a pro-arrhythmogenic protein increased during CVD, i.e., myocardial injury [116], atrial fibrillation [117], cardiac hypertrophy, and ischaemia/reperfusion injury [118], and inhibition of CaMKII might thus be a treatment option for cardiac pathologies [7,119,120].